2025-522412-16-00招募中1 期
An Open Label Study to Assess the Effect of Patient Use and Robustness on Tiotropium Bromide Spray 2.5μg, Soft Mist Inhaler device
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 75
- 试验地点
- 11
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Clara Paz Alvarez
Scientific
Laboratorios Liconsa S.A.
研究点 (11)
Loading locations...
相似试验
进行中（未招募）
1 期
anadelumab tested in patients suffering from hereditary angioedema with normal C1-Inhibitor.EUCTR2018-004136-30-DECharité - Universitätsmedizin Berlin Klinik für Dermatologie und Allergologie5
已完成
不适用
An open-label study to investigate the effects of emvododstat on the pharmacokinetics of CYP2D6 and BCRP substrates in healthy volunteersCancerNL-OMON50753PTC Therapeutics, Inc.36
已完成
不适用
An Open-Label Phase I Study to Assess the Effect of Rifampicin in the Pharmacokinetics of Eribulin Mesylate (E7389) in Subjects with Advanced Solid Tumoursdrug metabolism / cancer10027656NL-OMON32968Eisai14
进行中（未招募）
1 期
A Phase 2 study of AF37702 Injection for anemia in patients with pure red cell aplasia.EUCTR2005-004944-30-GBTakeda Development Centre Europe Ltd22
进行中（未招募）
1 期
A Phase 2 study of AF37702 Injection for anemia in patients with pure red cell aplasia.Anemia caused by Antibody-Mediated Pure Red Cell Aplasia in Patients with Chronic Kidney DiseaseMedDRA version: 18.0Level: PTClassification code 10002965Term: Aplasia pure red cellSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2005-004944-30-DETakeda Development Centre Europe Ltd40